Sign in
Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling
Journal article   Peer reviewed

Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling

Jeffrey Haessler, John D Shaughnessy, Abid Mohiuddin, Yazan Alsayed, Antje Hoering, Guido Tricot, Bart Barlogie, FENGHUANG Zhan, John Crowley, Joshua Epstein, …
Clinical cancer research, Vol.13(23), pp.7073-7079
01/12/2007
PMID: 18056185

Abstract

Antineoplastic agents Biological and medical sciences Hematologic and hematopoietic diseases Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Pharmacology. Drug treatments

Metrics

1 Record Views

Details